# Melatonin alleviates chronic intermittent hypoxia-induced gastric mucosal injury via attenuation of oxidative stress and JNK-mediated apoptotic signaling in rats

**Authors:** Hong L. Ji, Hua L. Yu, Jia F. Luo, Xin R. Li, Cheng X. Nie, Tie J. Liu, Huan H. Jiang, Cong H. Liu, Jia B. Zhang, Xin H. Yuan, Xiao F. Song, Yue D. Li, Yanlei Ge, Ai S. Fu

PMC · DOI: 10.1371/journal.pone.0338391 · PLOS One · 2026-01-13

## TL;DR

Melatonin protects rat stomach lining from damage caused by chronic low oxygen levels by reducing oxidative stress and preventing cell death.

## Contribution

This study identifies melatonin as a protective agent against hypoxia-induced gastric injury via modulation of oxidative stress and JNK signaling.

## Key findings

- Chronic intermittent hypoxia causes gastric damage through oxidative stress and JNK-mediated apoptosis.
- Melatonin treatment reduces oxidative stress markers and prevents apoptosis in hypoxia-exposed rats.
- Melatonin suppresses the JNK-Bax/Bcl-2 pathway, protecting gastric mucosa.

## Abstract

To investigate the mechanism of chronic intermittent hypoxia on gastric injury in rats and the intervening effect and possible mechanism of melatonin.

Forty-eight male Wistar rats were randomly divided into normal control, intermittent hypoxia, and melatonin treatment groups. Subgroups (n = 4 per time point) were treated for 2, 4, 6, and 8 weeks. Gastric tissue morphology, gastric juice pH, pepsin levels, oxidative stress markers (MDA and SOD), and the expression of JNK and apoptosis-related genes (Bax, Bcl-2) were assessed.

The intermittent hypoxia group exhibited significant gastric mucosal damage, decreased pH, increased pepsin, elevated MDA, reduced SOD, and upregulation of JNK and Bax/Bcl-2 mRNA ratio. Melatonin treatment markedly alleviated these pathological and molecular changes compared to the intermittent hypoxia group (P < 0.05).

Chronic intermittent hypoxia induces gastric mucosal injury, which is associated with oxidative stress imbalance and activation of JNK-mediated apoptotic signaling. Melatonin exerts a protective effect by enhancing antioxidant capacity and suppressing the JNK-Bax/Bcl-2 pathway.

## Linked entities

- **Genes:** MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596]
- **Chemicals:** melatonin (PubChem CID 896), MDA (PubChem CID 1614)

## Full-text entities

- **Genes:** Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, Rela (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 309165] {aka NFkB, nos2}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 116554] {aka JNK}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, TXNRD1 (thioredoxin reductase 1) [NCBI Gene 7296] {aka GRIM-12, TR, TR1, TRXR1, TXNR, TXNR1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}
- **Diseases:** Sleep deprivation (MESH:D012892), gastric injury (MESH:D013272), metabolic disorders (MESH:D008659), inflammation (MESH:D007249), stress ulcer (MESH:D000079225), systemic disease (MESH:D034721), pulmonary hypertension (MESH:D006976), NAFLD (MESH:D065626), respiratory disease (MESH:D012140), COPD (MESH:D029424), Chronic intermittent hypoxia (MESH:D000860), multi-system diseases (MESH:C000718087), cervical dislocation (MESH:D002575), chronic cough (MESH:D003371), Death (MESH:D003643), ischemia (MESH:D007511), gastroesophageal reflux (MESH:D005764), respiratory disorders (MESH:D012131), peptic ulcers (MESH:D010437), OSA (MESH:C535586), hemorrhage (MESH:D006470), asthma (MESH:D001249), ICH (MESH:D002543), gastrointestinal hemorrhage (MESH:D006471), OSAHS (MESH:D020181), gastric mucous membrane damage (MESH:D010390), cerebral infarction (MESH:D002544), liver injury (MESH:D017093)
- **Chemicals:** PBS (MESH:D007854), paraffin (MESH:D010232), MDA (MESH:D015104), hematoxylin (MESH:D006416), vitamin E (MESH:D014810), MDA (MESH:D008315), oil (MESH:D009821), sodium chloride (MESH:D012965), paraformaldehyde (MESH:C003043), ethanol (MESH:D000431), eosin (MESH:D004801), Oxygen (MESH:D010100), ROS (MESH:D017382), HE (MESH:D006371), Hematoxylin-eosin (-), MT (MESH:D008550), urethane (MESH:D014520), lipid (MESH:D008055), TRIzol (MESH:C411644), sodium hydroxide (MESH:D012972), nitrogen (MESH:D009584)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12799010/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12799010/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12799010/full.md

---
Source: https://tomesphere.com/paper/PMC12799010